Evidence map›Paper›PMID 32071067›Full record

ArticleImmunoHorizons2020

High-Dimensional Analysis of Postsplenectomy Peripheral Immune Cell Changes.

Jessica S W Borgers, Richard P Tobin, Victoria M Vorwald, Joshua M Smith, Dana M Davis, Abigail K Kimball, Eric T Clambey, Kasey L Couts, Jennifer A McWilliams, Kimberly R Jordan and 3 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in ImmunoHorizons, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Jessica S W BorgersDepartment of Surgery, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045.ORCID 0000-0002-6478-7821
Richard P TobinDepartment of Surgery, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045.
Victoria M VorwaldDepartment of Surgery, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045.
Joshua M SmithDepartment of Surgery, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045.
Dana M DavisUniversity of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, CO 80045.
Abigail K KimballDepartment of Anesthesiology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045.ORCID 0000-0002-9831-386X
Eric T ClambeyDepartment of Anesthesiology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045.ORCID 0000-0002-7972-9544
Kasey L CoutsDivision of Medical Oncology, Department of Medicine, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045; and.
Jennifer A McWilliamsDepartment of Immunology and Microbiology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045.
Kimberly R JordanDepartment of Immunology and Microbiology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045.
Robert J TorphyDepartment of Surgery, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045.
Richard SchulickDepartment of Surgery, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045.
Martin D McCarterDepartment of Surgery, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045; martin.mccarter@ucdenver.edu.
University of Colorado Anschutz Medical Campus · USUniversity of Colorado Cancer Center · USRadboud University Nijmegen · NL

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Transgenic and Gene Targeting CoreP30AR057212 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI NORRIS, DAVID A. · 2009 to 2018
$6.2M
NCI NIH HHS P30 CA046934NIAMS NIH HHS P30 AR057212
6 · The paper itself

Abstract

Although the consequences of splenectomy are well understood in mice, much less is known about the immunologic changes that occur following splenectomy in humans. We sought to characterize the circulating immune cell populations of patients before and after elective splenectomy to determine if these changes are related to postsplenectomy survival outcomes. Retrospective clinical information was collected from 95 patients undergoing elective splenectomy compared with 91 patients undergoing pancreaticoduodenectomy (Whipple procedure). We further analyzed peripheral blood from five patients in the splenectomy group, collected before and after surgery, using single-cell cytometry by time-of-flight mass spectrometry. We compared pre- and postsplenectomy data to characterize both the major and minor immune cell populations in significantly greater detail. Compared with patients undergoing a Whipple procedure, splenectomized patients had significant and long-lasting elevated counts of lymphocytes, monocytes, and basophils. Cytometry by time-of-flight mass spectroscopy analysis demonstrated that the elevated lymphocytes primarily consisted of naive CD4

Indexed as

AdultAgedAged, 80 and overBasophilsBiomarkersFemaleHumansLeukocyte CountLymphocytesLymphocyte SubsetsMaleMiddle AgedMonocytesMyeloid CellsPancreaticoduodenectomyPlatelet CountBiomarkersReceptors, CCR

Identifiers

PMID32071067
PMCPMC7476217
OpenAlexW3007834299

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.